Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Klotho Therapeutics announces series A financing to advance patent pending version of Klotho

Nov. 7, 2017

Ono Pharmaceutical divulges novel voltage-gated channel activators

Nov. 6, 2017

VS-505 effective and well tolerated hyperphosphatemia treatment for hemodialysis patients

Nov. 3, 2017

Cara Therapeutics doses first patient in study of CR-845

Oct. 26, 2017

FDA issues complete response letter for Xyosted

Oct. 23, 2017

Cara Therapeutics planning phase III pivotal program for CR-845

Oct. 17, 2017

Japan Tobacco enters licensing agreement for Rayaldee in Japan

Oct. 16, 2017

Vantia reports phase III topline data on fedovapagon for nocturia in men with BPH

Oct. 5, 2017

Soluble Nogo-B a potential treatment for diabetic glomerulopathy

Oct. 5, 2017

COLEC11, a possible therapeutic target for treating renal ischemia reperfusion injury

Oct. 2, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...